KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Labcorp Holdings (LH) EBT (2016 - 2025)

Labcorp Holdings (LH) has disclosed EBT for 17 consecutive years, with $190.6 million as the latest value for Q4 2025.

  • Quarterly EBT rose 3.7% to $190.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.1 billion through Dec 2025, up 15.42% year-over-year, with the annual reading at $1.1 billion for FY2025, 15.42% up from the prior year.
  • EBT hit $190.6 million in Q4 2025 for Labcorp Holdings, down from $337.0 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $1.0 billion in Q1 2021 to a low of -$147.1 million in Q4 2023.
  • Historically, EBT has averaged $342.5 million across 5 years, with a median of $286.3 million in 2024.
  • Biggest five-year swings in EBT: skyrocketed 481.7% in 2021 and later tumbled 1542.16% in 2023.
  • Year by year, EBT stood at $447.0 million in 2021, then tumbled by 97.72% to $10.2 million in 2022, then tumbled by 1542.16% to -$147.1 million in 2023, then soared by 224.95% to $183.8 million in 2024, then increased by 3.7% to $190.6 million in 2025.
  • Business Quant data shows EBT for LH at $190.6 million in Q4 2025, $337.0 million in Q3 2025, and $304.7 million in Q2 2025.